IMR Press / FBE / Special Issues / 1328642816182632542

Clinical antibody drug conjugates

Submission deadline: 31 December 2014
Special Issue Editor
  • Arthur E. Frankel
    Professor of Medicin, Scott and White Hospital, 2401 South 31st Street, Temple, Texas 76508
    Interests: 215 publications, 20 grants, Editor of Frontiers in Bioscience, Molecular Cancer Therapeutics, Clinical Cancer Research, Clinical Pharmacology:Advances and Applications
    Special Issues and Topics in IMR Press journals
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (1 Paper)
Back to top